Healthcare & Life Sciences

Altimmune, Inc.

United States
Sign in to unlock

About

Altimmune, Inc. is a clinical-stage biotechnology company focused on developing next-generation vaccines using two complementary vaccine delivery platforms to address respiratory diseases, chronic infections, cancer, and biodefense needs.

Explore Altimmune, Inc.'s full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing